Key Points
- President Dawn Christine Maroney sold a total of 130,000 shares (16,681 on Dec 12 at $20.02 and 113,319 on Dec 15 at $20.01) for about $2.60 million, leaving her with 1,780,556 shares valued at roughly $35.65 million.
- Alignment Healthcare shares trade near $20 (12‑month range $10.18–$21.06); the company posted 43.5% revenue growth year‑over‑year but still has negative EPS and margins, while analysts hold a consensus "Moderate Buy" with an average target of about $20.05.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 16,681 shares of the company's stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $20.02, for a total transaction of $333,953.62. Following the completion of the transaction, the president owned 1,780,556 shares in the company, valued at approximately $35,646,731.12. This trade represents a 0.93% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.
Dawn Christine Maroney also recently made the following trade(s):
- On Monday, December 15th, Dawn Christine Maroney sold 113,319 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.01, for a total value of $2,267,513.19.
Alignment Healthcare Price Performance
Alignment Healthcare stock opened at $20.11 on Tuesday. Alignment Healthcare, Inc. has a 12 month low of $10.18 and a 12 month high of $21.06. The stock's 50 day moving average is $17.71 and its 200-day moving average is $15.87. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. The company has a market capitalization of $4.02 billion, a price-to-earnings ratio of -167.58 and a beta of 1.16.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.03. The business had revenue of $993.70 million during the quarter, compared to analysts' expectations of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The firm's revenue for the quarter was up 43.5% compared to the same quarter last year. During the same period last year, the firm posted ($0.14) EPS. Equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.
Institutional Trading of Alignment Healthcare
Institutional investors have recently modified their holdings of the business. Mirabella Financial Services LLP bought a new position in Alignment Healthcare during the 3rd quarter worth $186,000. Hudson Bay Capital Management LP bought a new position in shares of Alignment Healthcare during the third quarter worth about $4,581,000. Allworth Financial LP lifted its stake in shares of Alignment Healthcare by 28.3% in the third quarter. Allworth Financial LP now owns 6,351 shares of the company's stock worth $111,000 after acquiring an additional 1,402 shares during the period. CIBC Bancorp USA Inc. bought a new stake in Alignment Healthcare in the third quarter valued at approximately $272,000. Finally, Maven Securities LTD acquired a new stake in Alignment Healthcare during the 3rd quarter valued at approximately $872,000. Institutional investors own 86.19% of the company's stock.
Analyst Ratings Changes
A number of brokerages have recently issued reports on ALHC. Wall Street Zen raised shares of Alignment Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, November 8th. UBS Group boosted their price objective on shares of Alignment Healthcare from $17.00 to $18.00 and gave the company a "neutral" rating in a report on Friday, October 31st. Barclays raised their target price on shares of Alignment Healthcare from $13.00 to $18.00 and gave the stock an "equal weight" rating in a report on Friday, October 31st. JPMorgan Chase & Co. upgraded Alignment Healthcare from a "neutral" rating to an "overweight" rating and boosted their price target for the company from $18.00 to $20.00 in a research note on Monday, November 24th. Finally, The Goldman Sachs Group reissued a "buy" rating and set a $22.00 price target on shares of Alignment Healthcare in a research report on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $20.05.
Check Out Our Latest Stock Analysis on ALHC
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
